Literature DB >> 8935633

Disseminated cryptococcosis with cutaneous lesions.

W Z Mostafa1, E A Ishak, E M Ekladious, H H Arnaout.   

Abstract

A case of disseminated cryptococcosis in an HIV-negative patient presenting with cutaneous lesions is described for the first time in Egypt. The patient, a 16-year-old male, presented with cough, expectoration, loss of weight, and cutaneous lesions, mainly on the face and trunk. The lesions consisted of vegetating crusted plaques discharging purulent to sanguinous fluid and flattened, shiny, erythematous to brownish plaques. Anorexia, headache and personality changes soon followed. Histopathological examination of lesions was highly suggestive of a deep mycosis, particularly cryptococcosis. The fulminant disease advanced with central nervous system involvement. The progression was not arrested when systemic antifungal therapy was administered late in the disease course. Pathological examination of lungs, liver, pancreas and spleen revealed disseminated infection with no evidence of other underlying pathology. Disseminated cryptococcosis is a morbid infection, rare in an area where heightened awareness and raised index of suspicion will surely allow earlier diagnosis, management and better prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8935633     DOI: 10.1111/j.1346-8138.1996.tb03999.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Petechial, purpuric, and ecchymotic presentation of cutaneous Cryptococcus in mantle cell lymphoma.

Authors:  Christie D Kimball; Allison Cruse; Lauren Craig; Joy King; Stephen Helms; Julie Wyatt; Jeremy Jackson; Robert Brodell
Journal:  JAAD Case Rep       Date:  2017-02-03

Review 2.  Cutaneous cryptococcosis: an underlying immunosuppression? Clinical manifestations, pathogenesis, diagnostic examinations and treatment.

Authors:  Marcela A Nowak; Anna Putynkowska; Wioletta Barańska-Rybak; Kamila Czarnacka; Maria A Dębska-Ślizień
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.